ProductLife Group, one of three global specialists in the regulatory affairs and pharmacovigilance market for major pharmaceutical companies, completed the acquisition of DS InPharmatics, a CMC consulting provider. Financial terms were not disclosed. "I’ve been very impressed by DSI. Their experts all have decades of practical industry and agencies interaction experience, providing an unparalleled perspective on how to navigate new product development in a complex and evolving regulatory environment and ultimately arrive at market in the most efficient way. We will leverage this experience to support our clients in their global efforts to accelerate the path to approval and to implement compliant drug development strategies," Xavier Duburcq, PLG CEO.